{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:44:18Z","timestamp":1761093858735,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.anai.2018.02.004","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T13:08:31Z","timestamp":1518181711000},"page":"668-669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rapid oral desensitization protocol to abiraterone acetate"],"prefix":"10.1016","volume":"120","author":[{"given":"Miriam","family":"Verdu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Torres-Degayon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Hassan-Bennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2018.02.004_bib0010","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s40265-013-0150-z","article-title":"Abiraterone acetate: a review of its use in patients with metastatic castration-resistant prostate cancer","volume":"73","author":"Hoy","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.anai.2018.02.004_bib0015","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/all.12142","article-title":"Skin test concentrations for systemically administered drugs: an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2018.02.004_bib0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/jjco\/hyp118","article-title":"Successful desensitization protocol for hypersensitivity reaction caused by sunitinib in a patient with a gastrointestinal stromal tumor","volume":"40","author":"Bar-Sela","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.anai.2018.02.004_bib0025","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/all.13119","article-title":"AllergoOncology: the impact of allergy in oncology: EAACI position paper","volume":"72","author":"Jensen-Jarolim","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2018.02.004_bib0030","first-page":"66","article-title":"Successful capecitabine desensitization for a delayed-type hypersensitivity reaction","volume":"26","author":"Demir","year":"2016","journal-title":"J Invest Allergol Clin Immunol"},{"key":"10.1016\/j.anai.2018.02.004_bib0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.anai.2016.06.013","article-title":"Severe adverse skin reaction and desensitization to sorafenib","volume":"117","author":"Linauskiene","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2018.02.004_bib0040","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1177\/1060028014535200","article-title":"Rapid oral desensitization to everolimus","volume":"48","author":"Karlin","year":"2014","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.anai.2018.02.004_bib0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.anai.2016.11.029","article-title":"Desensitization to acetazolamide in a patient with previous antimicrobial sulfonamide allergy","volume":"118","author":"Gharib","year":"2017","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120618301133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120618301133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:19:59Z","timestamp":1761052799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120618301133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1081120618301133"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2018.02.004","relation":{},"ISSN":["1081-1206"],"issn-type":[{"type":"print","value":"1081-1206"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid oral desensitization protocol to abiraterone acetate","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2018.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}